Lantheus increases to 12.16% shareholding in Radiopharm Theranostics Lantheus increases to 12.16% shareholding in Radiopharm Theranostics Post Contentlnth, radxRead More You might also be interested in reading SmartCentres REIT reports Q1 results. January 10, 2025 In Mainstream ← Previous post Next post →